Biotech IPOs: More to be Expected?

Oct 17, 2012, 09:00 AM by Michael Croft

Forbes | Are Biotech IPOs back? Two recent offerings netted 20% above their offer price.

October 17, 2012 | Are Biotech IPOs back? Two recent offerings netted 20% above their offer price, following a year of strong performances by the biotech sector. Forbes